Mizuho raised the firm’s price target on Dentsply Sirona (XRAY) to $14 from $13 and keeps a Neutral rating on the shares. Mizuho’s annual dental industry survey is more positive than prior years, the analyst tells investors in a research note. The firm upped targets in the dental group as part of its 2026 outlook.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona Renews Patterson Dental Technology Distribution Deal
- Dentsply Sirona, Patterson Dental renew U.S. dental distribution partnership
- Dentsply Sirona, Benco Dental expand partnership
- Dentsply Sirona appoints Donald Zurbay to board of directors
- Dentsply Sirona board establishes Growth and Value Creation Committee
